US Stock MarketDetailed Quotes

XERS Xeris Pharmaceuticals

Watchlist
  • 1.750
  • 0.0000.00%
Close Apr 30 16:00 ET
  • 1.711
  • -0.040-2.26%
Post 19:43 ET
259.44MMarket Cap-3888P/E (TTM)

Xeris Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
54.30%-47.02M
146.35%7.47M
17.71%-14.61M
33.31%-13.74M
46.00%-26.14M
-7.70%-102.89M
44.31%-16.12M
21.48%-17.75M
-2.93%-20.61M
-102.07%-48.41M
Net income from continuing operations
34.23%-62.26M
-3.56%-13.39M
44.17%-12.19M
24.22%-19.84M
50.07%-16.83M
22.87%-94.66M
74.54%-12.93M
16.06%-21.83M
4.83%-26.19M
-83.12%-33.71M
Operating gains losses
1,148.84%3.16M
114.29%2K
1,283.70%3.14M
----
----
-142.88%-301K
-101.77%-14K
380.25%227K
-6,260.00%-616K
610.00%102K
Depreciation and amortization
3.88%13.16M
-6.97%3.26M
9.31%3.36M
9.83%3.36M
4.91%3.18M
574.19%12.67M
289.66%3.5M
850.77%3.07M
856.88%3.06M
799.70%3.03M
Deferred tax
12.29%-1.25M
----
----
----
----
---1.42M
----
----
----
----
Other non cash items
-182.46%-3M
68.28%-1.6M
-212.81%-361K
-104.17%-222K
-126.72%-811K
277.94%3.63M
-2,257.26%-5.05M
36.17%320K
2,109.54%5.33M
1,109.16%3.04M
Change In working capital
82.09%-6.29M
692.72%17.83M
-328.23%-10.71M
108.20%445K
42.77%-13.86M
-396.52%-35.15M
-117.58%-3.01M
-206.12%-2.5M
-226.66%-5.43M
-177.44%-24.22M
-Change in receivables
37.44%-8.37M
304.38%6.77M
-793.36%-15.74M
126.76%635K
99.49%-30K
-114.43%-13.37M
-837.64%-3.31M
-39.18%-1.76M
29.31%-2.37M
-187.30%-5.93M
-Change in inventory
-98.31%-14.8M
74.55%-1.4M
-30.09%-2.15M
-4,922.30%-7.43M
-2,331.21%-3.82M
-0.63%-7.47M
-142.08%-5.51M
-31.56%-1.66M
63.37%-148K
95.49%-157K
-Change in prepaid assets
182.48%3.21M
280.34%2.04M
118.67%343K
337.78%2.05M
-2,012.07%-1.23M
-218.15%-3.89M
-130.71%-1.13M
-38.33%-1.84M
-190.18%-863K
-286.67%-58K
-Change in payables and accrued expense
146.21%6.44M
701.88%6.39M
90.79%4.02M
186.42%2.97M
39.85%-6.94M
-162.46%-13.93M
-106.78%-1.06M
-33.27%2.11M
-170.47%-3.43M
-721.79%-11.54M
-Change in other current liabilities
113.24%818K
199.33%893K
--684K
--3.27M
23.75%-4.03M
---6.18M
---899K
--0
--0
---5.28M
-Change in other working capital
-33.70%6.42M
-64.72%3.14M
230.60%2.14M
-174.95%-1.04M
273.71%2.18M
12,671.43%9.68M
2,265.21%8.9M
634.71%647K
-37.40%1.39M
28.85%-1.26M
Cash from discontinued investing activities
Operating cash flow
54.30%-47.02M
146.35%7.47M
17.71%-14.61M
33.31%-13.74M
46.00%-26.14M
-7.70%-102.89M
44.31%-16.12M
21.48%-17.75M
-2.93%-20.61M
-102.07%-48.41M
Investing cash flow
Cash flow from continuing investing activities
-117.42%-6M
62.17%14.87M
118.44%14.66M
-28.78%8.45M
-754.84%-43.98M
-64.82%34.46M
-74.95%9.17M
-63.74%6.71M
-28.32%11.87M
-74.46%6.72M
Capital expenditure reported
-331.87%-2.26M
0.00%-132K
-96.02%-345K
-567.24%-1.55M
-1,587.50%-238K
51.71%-524K
-0.76%-132K
42.67%-176K
-6.42%-232K
103.73%16K
Net business purchase and sale
--0
----
----
----
----
--0
----
----
----
----
Net investment purchase and sale
-110.69%-3.74M
61.29%15M
117.86%15M
-17.36%10M
-752.85%-43.74M
-42.25%34.99M
635.71%9.3M
-63.40%6.89M
-27.86%12.1M
-74.93%6.7M
Cash from discontinued investing activities
Investing cash flow
-117.42%-6M
62.17%14.87M
118.44%14.66M
-28.78%8.45M
-754.84%-43.98M
-64.82%34.46M
-74.95%9.17M
-63.74%6.71M
-28.32%11.87M
-74.46%6.72M
Financing cash flow
Cash flow from continuing financing activities
-101.27%-1.61M
-102.51%-1.23M
61.50%-72K
79.35%556K
-101.10%-863K
367.84%127.47M
39,224.80%49.16M
-18,800.00%-187K
-32.61%310K
193.29%78.19M
Net issuance payments of debt
--0
--0
--0
--0
--0
--102.72M
--48.92M
--0
--0
--53.8M
Net common stock issuance
-103.42%-1.01M
-133.33%-49K
-157.14%-72K
-733.33%-25K
-102.92%-863K
11.58%29.53M
87.57%-21K
---28K
---3K
11.07%29.58M
Proceeds from stock option exercised by employees
-30.50%581K
--0
--0
----
----
0.12%836K
8.16%318K
--0
-0.78%510K
-69.23%8K
Net other financing activities
78.89%-1.19M
----
----
----
----
-10,294.44%-5.61M
---60K
---159K
---197K
---5.2M
Cash from discontinued financing activities
Financing cash flow
-101.27%-1.61M
-102.51%-1.23M
61.50%-72K
79.35%556K
-101.10%-863K
367.84%127.47M
39,224.80%49.16M
-18,800.00%-187K
-32.61%310K
193.29%78.19M
Net cash flow
Beginning cash position
87.77%126.31M
-39.88%50.57M
-46.93%50.6M
-46.68%55.33M
87.77%126.31M
78.92%67.27M
41.38%84.11M
49.91%95.34M
55.80%103.77M
78.92%67.27M
Current changes in cash
-192.54%-54.64M
-49.99%21.11M
99.76%-27K
43.83%-4.74M
-294.47%-70.98M
98.96%59.04M
442.41%42.21M
-173.62%-11.23M
-180.47%-8.43M
25.84%36.5M
Effect of exchange rate changes
--0
----
----
--0
--0
--0
----
----
--0
---1K
End cash Position
-43.26%71.67M
-43.26%71.67M
-39.88%50.57M
-46.93%50.6M
-46.68%55.33M
87.77%126.31M
87.77%126.31M
41.38%84.11M
49.91%95.34M
55.80%103.77M
Free cash flow
52.34%-49.29M
145.16%7.34M
16.59%-14.96M
26.57%-15.29M
45.51%-26.38M
-7.03%-103.42M
44.11%-16.25M
21.76%-17.93M
-2.89%-20.83M
-98.52%-48.41M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 54.30%-47.02M146.35%7.47M17.71%-14.61M33.31%-13.74M46.00%-26.14M-7.70%-102.89M44.31%-16.12M21.48%-17.75M-2.93%-20.61M-102.07%-48.41M
Net income from continuing operations 34.23%-62.26M-3.56%-13.39M44.17%-12.19M24.22%-19.84M50.07%-16.83M22.87%-94.66M74.54%-12.93M16.06%-21.83M4.83%-26.19M-83.12%-33.71M
Operating gains losses 1,148.84%3.16M114.29%2K1,283.70%3.14M---------142.88%-301K-101.77%-14K380.25%227K-6,260.00%-616K610.00%102K
Depreciation and amortization 3.88%13.16M-6.97%3.26M9.31%3.36M9.83%3.36M4.91%3.18M574.19%12.67M289.66%3.5M850.77%3.07M856.88%3.06M799.70%3.03M
Deferred tax 12.29%-1.25M-------------------1.42M----------------
Other non cash items -182.46%-3M68.28%-1.6M-212.81%-361K-104.17%-222K-126.72%-811K277.94%3.63M-2,257.26%-5.05M36.17%320K2,109.54%5.33M1,109.16%3.04M
Change In working capital 82.09%-6.29M692.72%17.83M-328.23%-10.71M108.20%445K42.77%-13.86M-396.52%-35.15M-117.58%-3.01M-206.12%-2.5M-226.66%-5.43M-177.44%-24.22M
-Change in receivables 37.44%-8.37M304.38%6.77M-793.36%-15.74M126.76%635K99.49%-30K-114.43%-13.37M-837.64%-3.31M-39.18%-1.76M29.31%-2.37M-187.30%-5.93M
-Change in inventory -98.31%-14.8M74.55%-1.4M-30.09%-2.15M-4,922.30%-7.43M-2,331.21%-3.82M-0.63%-7.47M-142.08%-5.51M-31.56%-1.66M63.37%-148K95.49%-157K
-Change in prepaid assets 182.48%3.21M280.34%2.04M118.67%343K337.78%2.05M-2,012.07%-1.23M-218.15%-3.89M-130.71%-1.13M-38.33%-1.84M-190.18%-863K-286.67%-58K
-Change in payables and accrued expense 146.21%6.44M701.88%6.39M90.79%4.02M186.42%2.97M39.85%-6.94M-162.46%-13.93M-106.78%-1.06M-33.27%2.11M-170.47%-3.43M-721.79%-11.54M
-Change in other current liabilities 113.24%818K199.33%893K--684K--3.27M23.75%-4.03M---6.18M---899K--0--0---5.28M
-Change in other working capital -33.70%6.42M-64.72%3.14M230.60%2.14M-174.95%-1.04M273.71%2.18M12,671.43%9.68M2,265.21%8.9M634.71%647K-37.40%1.39M28.85%-1.26M
Cash from discontinued investing activities
Operating cash flow 54.30%-47.02M146.35%7.47M17.71%-14.61M33.31%-13.74M46.00%-26.14M-7.70%-102.89M44.31%-16.12M21.48%-17.75M-2.93%-20.61M-102.07%-48.41M
Investing cash flow
Cash flow from continuing investing activities -117.42%-6M62.17%14.87M118.44%14.66M-28.78%8.45M-754.84%-43.98M-64.82%34.46M-74.95%9.17M-63.74%6.71M-28.32%11.87M-74.46%6.72M
Capital expenditure reported -331.87%-2.26M0.00%-132K-96.02%-345K-567.24%-1.55M-1,587.50%-238K51.71%-524K-0.76%-132K42.67%-176K-6.42%-232K103.73%16K
Net business purchase and sale --0------------------0----------------
Net investment purchase and sale -110.69%-3.74M61.29%15M117.86%15M-17.36%10M-752.85%-43.74M-42.25%34.99M635.71%9.3M-63.40%6.89M-27.86%12.1M-74.93%6.7M
Cash from discontinued investing activities
Investing cash flow -117.42%-6M62.17%14.87M118.44%14.66M-28.78%8.45M-754.84%-43.98M-64.82%34.46M-74.95%9.17M-63.74%6.71M-28.32%11.87M-74.46%6.72M
Financing cash flow
Cash flow from continuing financing activities -101.27%-1.61M-102.51%-1.23M61.50%-72K79.35%556K-101.10%-863K367.84%127.47M39,224.80%49.16M-18,800.00%-187K-32.61%310K193.29%78.19M
Net issuance payments of debt --0--0--0--0--0--102.72M--48.92M--0--0--53.8M
Net common stock issuance -103.42%-1.01M-133.33%-49K-157.14%-72K-733.33%-25K-102.92%-863K11.58%29.53M87.57%-21K---28K---3K11.07%29.58M
Proceeds from stock option exercised by employees -30.50%581K--0--0--------0.12%836K8.16%318K--0-0.78%510K-69.23%8K
Net other financing activities 78.89%-1.19M-----------------10,294.44%-5.61M---60K---159K---197K---5.2M
Cash from discontinued financing activities
Financing cash flow -101.27%-1.61M-102.51%-1.23M61.50%-72K79.35%556K-101.10%-863K367.84%127.47M39,224.80%49.16M-18,800.00%-187K-32.61%310K193.29%78.19M
Net cash flow
Beginning cash position 87.77%126.31M-39.88%50.57M-46.93%50.6M-46.68%55.33M87.77%126.31M78.92%67.27M41.38%84.11M49.91%95.34M55.80%103.77M78.92%67.27M
Current changes in cash -192.54%-54.64M-49.99%21.11M99.76%-27K43.83%-4.74M-294.47%-70.98M98.96%59.04M442.41%42.21M-173.62%-11.23M-180.47%-8.43M25.84%36.5M
Effect of exchange rate changes --0----------0--0--0----------0---1K
End cash Position -43.26%71.67M-43.26%71.67M-39.88%50.57M-46.93%50.6M-46.68%55.33M87.77%126.31M87.77%126.31M41.38%84.11M49.91%95.34M55.80%103.77M
Free cash flow 52.34%-49.29M145.16%7.34M16.59%-14.96M26.57%-15.29M45.51%-26.38M-7.03%-103.42M44.11%-16.25M21.76%-17.93M-2.89%-20.83M-98.52%-48.41M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg